Skip to main content

IGM Biosciences, Inc.

IGMSDelisted Aug 14, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001496323

IGM Biosciences, Inc. was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 18, 2025; 66 institutions reported holding it in 13F filings for Q2 2025, worth $17.9M in total; no superinvestor held it.

Q2 2024 vs. Q1 2024

How the institutions holding IGM Biosciences, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of IGMS: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders8782−5
Shares22.8M22.3M−563.3K (−2.5%)
Value$220.3M$152.9M−$67.3M (−30.6%)

New holders (13)

Institutions that held IGM Biosciences, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to IGMS in Q2 2024
InstitutionSharesValue% of portfolio
Corton Capital Inc.63,336$435.1K0.23%
Hudson Bay Capital Management LP46,119$316.8K0.00%
Point72 Asset Management, L.P.27,246$187.2K0.00%
Verition Fund Management LLC26,120$179.4K0.00%
Jump Financial, LLC19,200$131.9K0.00%
Tudor Investment Corp Et Al14,537$99.9K0.00%
AQR Capital Management LLC12,230$84.0K0.00%
Corebridge Financial, Inc.8,162$56.1K0.00%
Mirae Asset Global ETFs Holdings Ltd.6,508$44.7K0.00%
Cubist Systematic Strategies, LLC3,300$22.7K0.00%
Simplex Trading, LLC759$5.00K0.00%
Quarry LP197$1.35K0.00%
Advisor Group Holdings, Inc.59$4050.00%

Sold out (18)

Institutions that held IGM Biosciences, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.